<html>
<head>
<title>Utah Legislature HB0050</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>OPIOID PRESCRIBING REGULATIONS</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2017 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Raymond P. Ward</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill amends the Division of Occupational and Professional Licensing Act related to<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescribing of certain controlled substances.<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;limits the number of days for which an opiate may be prescribed for certain<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individuals;<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;removes an outdated provision from the Utah Controlled Substances Act related to<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate prescribing; and<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends provisions of the Controlled Substance Database Act related to provider use<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of the database.<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37-6">58-37-6</a></b>, as last amended by Laws of Utah 2014, Chapter 78<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-304">58-37f-304</a></b>, as enacted by Laws of Utah 2016, Chapter 275<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>58-37-6</b><a name="58-37-6"></a> is amended to read:<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-37-6.</b>   <a name="toposec"></a><b>License to manufacture, produce, distribute, dispense, administer, or</b><br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>conduct research -- Issuance by division -- Denial, suspension, or revocation -- Records</b><br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>required -- Prescriptions.</b><br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a)  The division may adopt rules relating to the licensing and control of the<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manufacture, distribution, production, prescription, administration, dispensing, conducting of<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research with, and performing of laboratory analysis upon controlled substances within this<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;state.<br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  The division may assess reasonable fees to defray the cost of issuing original and<br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;renewal licenses under this chapter pursuant to Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63j-1-504&session=2017GS">63J-1-504</a><a name="toposearch"></a>.<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) (a) (i)  Every person who manufactures, produces, distributes, prescribes, dispenses,<br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administers, conducts research with, or performs laboratory analysis upon any controlled<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance in Schedules I through V within this state, or who proposes to engage in<br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manufacturing, producing, distributing, prescribing, dispensing, administering, conducting<br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research with, or performing laboratory analysis upon controlled substances included in<br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedules I through V within this state shall obtain a license issued by the division.<br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  The division shall issue each license under this chapter in accordance with a<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;two-year renewal cycle established by rule.  The division may by rule extend or shorten a<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;renewal period by as much as one year to stagger the renewal cycles it administers.<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  Persons licensed to manufacture, produce, distribute, prescribe, dispense,<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administer, conduct research with, or perform laboratory analysis upon controlled substances in<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedules I through V within this state may possess, manufacture, produce, distribute,<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;those substances to the extent authorized by their license and in conformity with this chapter.<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  The following persons are not required to obtain a license and may lawfully possess<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substances included in Schedules II through V under this section:<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  an agent or employee, except a sales representative, of any registered manufacturer,<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;distributor, or dispenser of any controlled substance, if the agent or employee is acting in the<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;usual course of the person's business or employment; however, nothing in this subsection shall<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;be interpreted to permit an agent, employee, sales representative, or detail man to maintain an<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inventory of controlled substances separate from the location of the person's employer's<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;registered and licensed place of business;<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  a motor carrier or warehouseman, or an employee of a motor carrier or<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;warehouseman, who possesses any controlled substance in the usual course of the person's<br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;business or employment; and<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  an ultimate user, or any person who possesses any controlled substance pursuant to<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a lawful order of a practitioner.<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  The division may enact rules waiving the license requirement for certain<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manufacturers, producers, distributors, prescribers, dispensers, administrators, research<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practitioners, or laboratories performing analysis if consistent with the public health and safety.<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  A separate license is required at each principal place of business or professional<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practice where the applicant manufactures, produces, distributes, dispenses, conducts research<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with, or performs laboratory analysis upon controlled substances.<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  The division may enact rules providing for the inspection of a licensee or applicant's<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establishment, and may inspect the establishment according to those rules.<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) (a) (i)  Upon proper application, the division shall license a qualified applicant to<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substances included in Schedules I through V, unless it determines that issuance of a<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;license is inconsistent with the public interest.<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  The division may not issue a license to any person to prescribe, dispense, or<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administer a Schedule I controlled substance except under Subsection (3)(a)(i).<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  In determining public interest under this Subsection (3)(a), the division shall<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consider whether or not the applicant has:<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  maintained effective controls against diversion of controlled substances and any<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedule I or II substance compounded from any controlled substance into other than<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;legitimate medical, scientific, or industrial channels;<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  complied with applicable state and local law;<br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)  been convicted under federal or state laws relating to the manufacture, distribution,<br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or dispensing of substances;<br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)  past experience in the manufacture of controlled dangerous substances;<br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E)  established effective controls against diversion; and<br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(F)  complied with any other factors that the division establishes that promote the public<br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health and safety.<br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,<br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;produce, distribute, conduct research with, or perform laboratory analysis upon controlled<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substances in Schedule I other than those specified in the license.<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)  Practitioners shall be licensed to administer, dispense, or conduct research with<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substances in Schedules II through V if they are authorized to administer, dispense, or conduct<br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research under the laws of this state.<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  The division need not require a separate license for practitioners engaging in<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research with nonnarcotic controlled substances in Schedules II through V where the licensee is<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;already licensed under this chapter in another capacity.<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  With respect to research involving narcotic substances in Schedules II through V,<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or where the division by rule requires a separate license for research of nonnarcotic substances<br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in Schedules II through V, a practitioner shall apply to the division prior to conducting<br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research.<br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  Licensing for purposes of bona fide research with controlled substances by a<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practitioner considered qualified may be denied only on a ground specified in Subsection (4),<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard<br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;adequately the practitioner's supply of substances against diversion from medical or scientific<br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use.<br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)  Practitioners registered under federal law to conduct research in Schedule I<br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substances may conduct research in Schedule I substances within this state upon furnishing the<br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;division evidence of federal registration.<br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  Compliance by manufacturers, producers, and distributors with the provisions of<br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;federal law respecting registration, excluding fees, entitles them to be licensed under this<br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chapter.<br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  The division shall initially license those persons who own or operate an<br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establishment engaged in the manufacture, production, distribution, dispensation, or<br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administration of controlled substances prior to April 3, 1980, and who are licensed by the<br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;state.<br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) (a)  Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed<br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;on probation, or revoked by the division upon finding that the applicant or licensee has:<br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  materially falsified any application filed or required pursuant to this chapter;<br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  been convicted of an offense under this chapter or any law of the United States, or<br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any state, relating to any substance defined as a controlled substance;<br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  been convicted of a felony under any other law of the United States or any state<br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;within five years of the date of the issuance of the license;<br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  had a federal registration or license denied, suspended, or revoked by competent<br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;federal authority and is no longer authorized to manufacture, distribute, prescribe, or dispense<br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substances;<br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)  had the licensee's license suspended or revoked by competent authority of another<br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;state for violation of laws or regulations comparable to those of this state relating to the<br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;manufacture, distribution, or dispensing of controlled substances;<br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)  violated any division rule that reflects adversely on the licensee's reliability and<br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;integrity with respect to controlled substances;<br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)  refused inspection of records required to be maintained under this chapter by a<br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;person authorized to inspect them; or<br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)  prescribed, dispensed, administered, or injected an anabolic steroid for the<br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;purpose of manipulating human hormonal structure so as to:<br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  increase muscle mass, strength, or weight without medical necessity and without a<br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;written prescription by any practitioner in the course of the practitioner's professional practice;<br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or<br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  improve performance in any form of human exercise, sport, or game.<br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  The division may limit revocation or suspension of a license to a particular<br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance with respect to which grounds for revocation or suspension exist.<br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)  Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to<br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of<br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Occupational and Professional Licensing Act, and conducted in conjunction with the<br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appropriate representative committee designated by the director of the department.<br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  Nothing in this Subsection (4)(c) gives the Division of Occupational and<br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,<br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except where the division is designated by law to perform those functions, or, when not<br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designated by law, is designated by the executive director of the Department of Commerce to<br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;conduct the proceedings.<br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) (i)  The division may suspend any license simultaneously with the institution of<br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;proceedings under this section if it finds there is an imminent danger to the public health or<br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;safety.<br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  Suspension shall continue in effect until the conclusion of proceedings, including<br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;judicial review, unless withdrawn by the division or dissolved by a court of competent<br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jurisdiction.<br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) (i)  If a license is suspended or revoked under this Subsection (4), all controlled<br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substances owned or possessed by the licensee may be placed under seal in the discretion of the<br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;division.<br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  Disposition may not be made of substances under seal until the time for taking an<br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,<br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;orders the sale of perishable substances and the proceeds deposited with the court.<br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  If a revocation order becomes final, all controlled substances shall be forfeited.<br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  The division shall notify promptly the Drug Enforcement Administration of all<br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;orders suspending or revoking a license and all forfeitures of controlled substances.<br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  If an individual's Drug Enforcement Administration registration is denied, revoked,<br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;surrendered, or suspended, the division shall immediately suspend the individual's controlled<br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance license, which shall only be reinstated by the division upon reinstatement of the<br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;federal registration, unless the division has taken further administrative action under<br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (4)(a)(iv), which would be grounds for the continued denial of the controlled<br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance license.<br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) (a)  Persons licensed under Subsection (2) or (3) shall maintain records and<br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inventories in conformance with the record keeping and inventory requirements of federal and<br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;state law and any additional rules issued by the division.<br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) (i)  Every physician, dentist, naturopathic physician, veterinarian, practitioner, or<br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other person who is authorized to administer or professionally use a controlled substance shall<br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;keep a record of the drugs received by him and a record of all drugs administered, dispensed, or<br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;professionally used by him otherwise than by a prescription.<br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  A person using small quantities or solutions or other preparations of those drugs for<br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;local application has complied with this Subsection (5)(b) if the person keeps a record of the<br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;quantity, character, and potency of those solutions or preparations purchased or prepared by<br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;him, and of the dates when purchased or prepared.<br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)  Controlled substances in Schedules I through V may be distributed only by a<br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;licensee and pursuant to an order form prepared in compliance with division rules or a lawful<br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;order under the rules and regulations of the United States.<br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) (a)  A person may not write or authorize a prescription for a controlled substance<br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unless the person is:<br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  a practitioner authorized to prescribe drugs and medicine under the laws of this state<br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or under the laws of another state having similar standards; and<br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  licensed under this chapter or under the laws of another state having similar<br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;standards.<br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  A person other than a pharmacist licensed under the laws of this state, or the<br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pharmacist's licensed intern, as required by Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-303&session=2017GS">58-17b-303</a> and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-304&session=2017GS">58-17b-304</a>, may not<br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispense a controlled substance.<br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)  A controlled substance may not be dispensed without the written prescription of<br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a practitioner, if the written prescription is required by the federal Controlled Substances Act.<br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  That written prescription shall be made in accordance with Subsection (7)(a) and in<br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;conformity with Subsection (7)(d).<br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  In emergency situations, as defined by division rule, controlled substances may be<br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms<br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designated by the division and filed by the pharmacy.<br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  Prescriptions reduced to writing by a pharmacist shall be in conformity with<br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (7)(d).<br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  Except for emergency situations designated by the division, a person may not issue,<br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fill, compound, or dispense a prescription for a controlled substance unless the prescription is<br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;signed by the prescriber in ink or indelible pencil or is signed with an electronic signature of<br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the prescriber as authorized by division rule, and contains the following information:<br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the name, address, and registry number of the prescriber;<br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the name, address, and age of the person to whom or for whom the prescription is<br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issued;<br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the date of issuance of the prescription; and<br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  the name, quantity, and specific directions for use by the ultimate user of the<br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance.<br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  A prescription may not be written, issued, filled, or dispensed for a Schedule I<br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance unless:<br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the person who writes the prescription is licensed under Subsection (2); and<br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the prescribed controlled substance is to be used in research.<br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  Except when administered directly to an ultimate user by a licensed practitioner,<br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substances are subject to the [<strike>following</strike>] restrictions[<strike>:</strike>] <u>of this Subsection (7)(f).</u><br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) [<strike>(A)</strike>]  A prescription for a Schedule II substance may not be refilled.<br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(B)</strike>] <u>(ii)</u>  A Schedule II controlled substance may not be filled in a quantity to exceed a<br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;one-month's supply, as directed on the daily dosage rate of the prescriptions.<br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  If an individual has not filled a prescription for a Schedule II or III controlled</u><br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>substance that is an opiate within the last 90 days, a Schedule II or III controlled substance that</u><br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>is an opiate may not be filled in a quantity to exceed a seven day supply as directed on the daily</u><br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>dosage rate of the prescription.</u><br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(ii)</strike>] <u>(iv)</u>  A Schedule III or IV controlled substance may be filled only within six<br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;months of issuance, and may not be refilled more than six months after the date of its original<br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issuance or be refilled more than five times after the date of the prescription unless renewed by<br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the practitioner.<br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(iii)</strike>] <u>(v)</u>  All other controlled substances in Schedule V may be refilled as the<br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescriber's prescription directs, but they may not be refilled one year after the date the<br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescription was issued unless renewed by the practitioner.<br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(iv)</strike>] <u>(vi)</u>  Any prescription for a Schedule II substance may not be dispensed if it is not<br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days<br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;after the date the prescription was issued, or 30 days after the dispensing date, if that date is<br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;specified separately from the date of issue.<br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(v)</strike>] <u>(vii)</u>  A practitioner may issue more than one prescription at the same time for the<br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;same Schedule II controlled substance, but only under the following conditions:<br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  no more than three prescriptions for the same Schedule II controlled substance may<br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;be issued at the same time;<br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  no one prescription may exceed a 30-day supply; <u>and</u><br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)  a second or third prescription shall include the date of issuance and the date for<br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensing[<strike>; and</strike>]<u>.</u><br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(D)  unless the practitioner determines there is a valid medical reason to the contrary,</strike><br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>the date for dispensing a second or third prescription may not be fewer than 30 days from the</strike><br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>dispensing date of the previous prescription.</strike>]<br/>251&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  An order for a controlled substance in Schedules II through V for use by an<br/>252&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inpatient or an outpatient of a licensed hospital is exempt from all requirements of this<br/>253&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (7) if the order is:<br/>254&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  issued or made by a prescribing practitioner who holds an unrestricted registration<br/>255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with the federal Drug Enforcement Administration, and an active Utah controlled substance<br/>256&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;license in good standing issued by the division under this section, or a medical resident who is<br/>257&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exempted from licensure under Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-307&session=2017GS">58-1-307</a>(1)(c);<br/>258&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  authorized by the prescribing practitioner treating the patient and the prescribing<br/>259&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practitioner designates the quantity ordered;<br/>260&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  entered upon the record of the patient, the record is signed by the prescriber<br/>261&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;affirming the prescriber's authorization of the order within 48 hours after filling or<br/>262&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;administering the order, and the patient's record reflects the quantity actually administered; and<br/>263&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  filled and dispensed by a pharmacist practicing the pharmacist's profession within<br/>264&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the physical structure of the hospital, or the order is taken from a supply lawfully maintained by<br/>265&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the hospital and the amount taken from the supply is administered directly to the patient<br/>266&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorized to receive it.<br/>267&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)  A practitioner licensed under this chapter may not prescribe, administer, or<br/>268&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispense a controlled substance to a child, without first obtaining the consent required in<br/>269&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=78b-3-406&session=2017GS">78B-3-406</a> of a parent, guardian, or person standing in loco parentis of the child except<br/>270&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in cases of an emergency.  For purposes of this Subsection (7)(h), "child" has the same<br/>271&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;meaning as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=78a-6-105&session=2017GS">78A-6-105</a>, and "emergency" means any physical condition<br/>272&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requiring the administration of a controlled substance for immediate relief of pain or suffering.<br/>273&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  A practitioner licensed under this chapter may not prescribe or administer dosages<br/>274&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of a controlled substance in excess of medically recognized quantities necessary to treat the<br/>275&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ailment, malady, or condition of the ultimate user.<br/><hr>276&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)  A practitioner licensed under this chapter may not prescribe, administer, or dispense<br/>277&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any controlled substance to another person knowing that the other person is using a false name,<br/>278&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;address, or other personal information for the purpose of securing the controlled substance.<br/>279&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)  A person who is licensed under this chapter to manufacture, distribute, or dispense<br/>280&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a controlled substance may not manufacture, distribute, or dispense a controlled substance to<br/>281&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;another licensee or any other authorized person not authorized by this license.<br/>282&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)  A person licensed under this chapter may not omit, remove, alter, or obliterate a<br/>283&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;symbol required by this chapter or by a rule issued under this chapter.<br/>284&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)  A person licensed under this chapter may not refuse or fail to make, keep, or<br/>285&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;furnish any record notification, order form, statement, invoice, or information required under<br/>286&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this chapter.<br/>287&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)  A person licensed under this chapter may not refuse entry into any premises for<br/>288&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;inspection as authorized by this chapter.<br/>289&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)  A person licensed under this chapter may not furnish false or fraudulent material<br/>290&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;information in any application, report, or other document required to be kept by this chapter or<br/>291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;willfully make any false statement in any prescription, order, report, or record required by this<br/>292&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chapter.<br/>293&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) (a) (i)  Any person licensed under this chapter who is found by the division to have<br/>294&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;violated any of the provisions of Subsections (7)(k) through (o) or Subsection (10) is subject to<br/>295&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a penalty not to exceed $5,000.  The division shall determine the procedure for adjudication of<br/>296&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any violations in accordance with Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-106&session=2017GS">58-1-106</a> and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-108&session=2017GS">58-1-108</a>.<br/>297&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  The division shall deposit all penalties collected under Subsection (8)(a)(i) in the<br/>298&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Fund as a dedicated credit to be used by the division under Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-502&session=2017GS">58-37f-502</a>(1).<br/>299&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  Any person who knowingly and intentionally violates Subsections (7)(h) through (j)<br/>300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or Subsection (10) is:<br/>301&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  upon first conviction, guilty of a class B misdemeanor;<br/>302&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  upon second conviction, guilty of a class A misdemeanor; and<br/>303&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  on third or subsequent conviction, guilty of a third degree felony.<br/>304&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  Any person who knowingly and intentionally violates Subsections (7)(k) through<br/>305&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) shall upon conviction be guilty of a third degree felony.<br/>306&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)  Any information communicated to any licensed practitioner in an attempt to<br/><hr>307&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unlawfully procure, or to procure the administration of, a controlled substance is not considered<br/>308&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to be a privileged communication.<br/>309&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10)  A person holding a valid license under this chapter who is engaged in medical<br/>310&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research may produce, possess, administer, prescribe, or dispense a controlled substance for<br/>311&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;research purposes as licensed under Subsection (2) but may not otherwise prescribe or dispense<br/>312&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a controlled substance listed in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4.2&session=2017GS">58-37-4.2</a>.<br/>313&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>58-37f-304</b><a name="58-37f-304"></a> is amended to read:<br/>314&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-37f-304.</b>   <b>Database utilization.</b><br/>315&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  As used in this section:<br/>316&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  "Dispenser" means a licensed pharmacist, as described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-303&session=2017GS">58-17b-303</a>, or<br/>317&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the pharmacist's licensed intern, as described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-304&session=2017GS">58-17b-304</a>, who is also licensed to<br/>318&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispense a controlled substance under Title 58, Chapter 37, Utah Controlled Substances Act.<br/>319&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(b)  "Opioid" means those substances listed in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4&session=2017GS">58-37-4</a>(2)(b)(i) or</strike><br/>320&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>(2)(b)(ii).</strike>]<br/>321&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(c)</strike>] <u>(b)</u>  "Outpatient" means a setting in which an individual visits a licensed<br/>322&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;healthcare facility or a healthcare provider's office for a diagnosis or treatment but is not<br/>323&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;admitted to a licensed healthcare facility for an overnight stay.<br/>324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(d)</strike>] <u>(c)</u>  "Prescriber" means an individual authorized to prescribe a controlled<br/>325&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance under Title 58, Chapter 37, Utah Controlled Substances Act.<br/>326&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)  To address the serious public health concern of life-altering and life-threatening</strike><br/>327&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>opioid abuse and overdose, and to achieve the purposes of this chapter and as described in</strike><br/>328&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-201&session=2017GS">58-37f-201</a>, which includes identifying and reducing the prescribing and dispensing of</strike><br/>329&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>opioids in an unprofessional or unlawful manner or in quantities or frequencies inconsistent</strike><br/>330&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>with generally recognized standards of dosage for an opioid, through utilization of the carefully</strike><br/>331&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>developed and highly respected database:</strike>]<br/>332&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(a)  a prescriber or dispenser of an opioid for individual outpatient usage shall access</strike><br/>333&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>and review the database as necessary in the prescriber's or dispenser's professional judgment</strike><br/>334&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>and to achieve the purpose of this chapter as described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-201&session=2017GS">58-37f-201</a>; (b) a</strike>]<br/>335&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Schedule II opioid" means those substances listed in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4&session=2017GS">58-37-4</a>(2)(b)(i)</u><br/>336&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>or (2)(b)(ii).</u><br/>337&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Schedule III opioid" means those substances listed in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4&session=2017GS">58-37-4</a>(2)(c)</u><br/><hr>338&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>that are opioids.</u><br/>339&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2) (a)  Except as provided in Subsection (2)(b), a prescriber shall check the database</u><br/>340&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>for information about a patient before the first time the prescriber gives a prescription to a</u><br/>341&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>patient for a Schedule II opioid or a Schedule III opioid.</u><br/>342&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  A prescriber is not required to check the database under Subsection (2)(a) if:</u><br/>343&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the prescription for a Schedule II opioid or a Schedule III opioid is for three days or</u><br/>344&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>fewer on the daily dosage instructions on the prescription; or</u><br/>345&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  the prescriber has prior knowledge of the patient's history based on the previous</u><br/>346&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>interactions between the patient and the prescriber, or through the prescriber's access to the</u><br/>347&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>patient's health records.</u><br/>348&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  If a prescriber is repeatedly prescribing a Schedule II opioid or Schedule III opioid</u><br/>349&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>to a patient, the prescriber shall periodically review information about the patient in:</u><br/>350&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the database, or</u><br/>351&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  other similar records of controlled substances the patient has filled.</u><br/>352&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  A</u> prescriber may assign the access and review required under [<strike>Subsection</strike>]<br/>353&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsections</u> (2)(a) <u>and (2)(c)</u> to an employee, in accordance with Subsections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-301&session=2017GS">58-37f-301</a>(2)(g)<br/>354&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and (h).<br/>355&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The division shall, in collaboration with the licensing boards for prescribers and<br/>356&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensers:<br/>357&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  develop a system that gathers and reports to prescribers and dispensers the progress<br/>358&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and results of the prescriber's and dispenser's individual access and review of the database, as<br/>359&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided in this section; and<br/>360&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  reduce or waive the division's continuing education requirements regarding opioid<br/>361&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescriptions, described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-6.5&session=2017GS">58-37-6.5</a>, including the online tutorial and test relating to<br/>362&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database, for prescribers and dispensers whose individual utilization of the database<br/>363&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>contribute to the life-saving and public safety purposes of this section and as described in</strike><br/>364&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>Subsection (2).</strike>]<u>, as determined by the division, demonstrates substantial compliance with this</u><br/>365&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>section.</u><br/>366&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)  If the dispenser's access and review of the database suggest that the individual<br/>367&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;seeking an opioid may be obtaining opioids in quantities or frequencies inconsistent with<br/>368&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;generally recognized standards as provided in this section and Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-201&session=2017GS">58-37f-201</a>, the<br/><hr>369&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispenser shall reasonably attempt to contact the prescriber to obtain the prescriber's informed,<br/>370&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;current, and professional decision regarding whether the prescribed opioid is medically<br/>371&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;justified, notwithstanding the results of the database search.<br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
